Cannabis Science Inc. Cannabis Science Inc.
Cannabis Science Inc. Cannabis Science Inc.
  • Home
  • About Us
    • Corporate Overview
    • Mission Statement
    • Cannabis Science Team
    • Careers & Corporate Culture
  • iCannabinoid
    • Join Now!
  • R&D
    • The Science of Cannabinoids
    • CBIS Cannabinoid Research
    • Critical Ailments
  • COLLABORATIONS & PROJECTS
    • CBIS Medical Consortium
    • Global Economic Development
    • Pan African A & C University
    •     African Economic Initiative
    • American States University
    •     North American Economic Initiative
    • Dana-Farber
    • CFA
    • Stellenbosch University
    • CBIS Bottle It
  • Products & Pharmacies
    • Products
    • Order Online
    • Pharmacies
  • Investors
    • CBIS Current Share Structure
    • SEC Filings
  • Media
    • CBIS News Releases
    • CBIS In The News
    • CBIS Events
  • Contact

latest Articles

  • Cannabis Science Issues 2019 Guidance Report; Under SEC Sanctions the Company Goes Private as It Enters Into Step (2) of Its Growth Transition, Enabling Full Transparency and Revenue Growth
  • Cannabis Science Enters Transition Stage as Trading of the Company’s Shares is Halted; The Company Will Continue to Implement Its Growth Strategy and Resolve All Outstanding Fully Reporting Requirements
  • Cannabis Science Partners With CDN Firm NHS Industries to Launch the CBIS CDN Economic Development Plan; CBIS to Use Its Relations With the Harvard International Phytomedicines and Medical Cannabis Institute and Other Leading Institutions
  • Cannabis Science Prepares Announcements for Revenues and Corporate Growth; Finalizing New Asset Partnerships and Acquisitions Targeting Positive Cash Flow in Key Markets Globally
  • Cannabis Science Successfully Completes European Headquarters and Operations Move to The Netherlands and Completes Shut Down of All Cannabis Science Europe GmbH Germany Operations

  1. Home

Total: 448 results found.

Page 19 of 23

Cannabis Science Selects Influential Southern California Financial Firm as the Lead to Raise the Proposed 25 Million USD in Expansion Capital and Boost its Industry Footprint

Created on 2018-02-16 00:12:37

Cannabis Science Senior Executives Arrive at the Global Health Catalyst Summit at Harvard Medical School

Created on 2018-02-16 00:11:12

Cannabis Science Senior Executives Chair Special Sessions and Deliver a Keynote Speech at the Global Health Catalyst Summit at Harvard Medical School

Created on 2018-02-15 23:10:12

Cannabis Science Releases First Test Batch of Suppositories to Aid Self-Medicating Patients That Require Alternative Delivery Methods With Severe Pain and Symptoms Related to Cancers, Anxiety, and Insomnia

Created on 2018-02-15 23:09:04

Cannabis Science, Inc. Receives U.S. Federal Government Clearance to Receive U.S. Federal Government Contracts

Created on 2018-02-15 22:46:32

UPDATE - Cannabis Science Releases the Chronic Pain CBIS Transdermal Patches to Meet the Overwhelming Demand from Self-Medicating Patients Worldwide as it Continues to Expands its California Dispensary Network

Created on 2018-02-15 22:45:17

Cannabis Science Invests in the Research and Development of Cannabinoid-based Medications to Treat COPD and Asthma

Created on 2018-02-15 22:01:08

Cannabis Science Calls on All MMJ Companies to Recognize and Join the Fight Against Opioid Addiction and Deaths by Supporting Self-Medicating Patients to fight Opioid Abuse by Using all Forms of Ingested MMJ as a Viable Gateway out of Extreme Opioid Usage

Created on 2018-02-15 22:00:01

Cannabis Science Releases its 2017 Guidance Report for 2nd Quarter 2017, and Outlines Company's Performance and Growth Opportunities as the Medical Cannabis Industry Expands Dramatically

Created on 2018-02-15 21:58:49

Cannabis Science Steps Up the Fight Against Opioid Drug Addictions with its Initial Test Batch of Transdermal Patches and Unisex Rectal Suppositories Available Now in Los Angeles Dispensaries, Meeting a Growing Demand from Self-Medicating Patients

Created on 2018-02-15 21:57:44

Cannabis Science, Inc. Finds Large-Scale Manufacturing and Product Distribution Facility in California and Eyes Nevada Property as Nevada Governor Issues Statement of Emergency Due to Potential Shortage of Cannabis

Created on 2018-02-15 21:54:22

Cannabis Science Issues Second Quarter Update Looking Forward to More Quarterly Growth and Progress Reports with More New and Exciting Revenue Developments Coming Soon

Created on 2018-02-15 21:49:35

Cannabis Science 2017 Black Tie Gala Event Draws Near as Cannabis Science Completes Major Milestones and Operational Goals

Created on 2018-02-15 21:48:12

Cannabis Science and Free Spirit Organics Native American Corporation (FSO NAC) Begin Harvesting Approximately 60 Acres of its 250-Acre Industrial Hemp Project on San Joaquin Sovereign Tribal Fee Land MBS, California

Created on 2018-02-15 21:47:18

Breaking News: CBIS/FSAO NAC Harvest Planning Session Held Yesterday Has Accelerated the Completion of the 60-acre Industrial Hemp Project Planted on the 250 acre CBIS/FSO NAC MBS001 Plot Currently Under Harvest

Created on 2018-02-15 21:45:58

Cannabis Science Launches a Global Consortium and Announces Updates on Its Drug Development Initiatives and Research Collaborations

Created on 2018-02-15 21:40:08

Cannabis Science and Free Spirit Organics Advance Comprehensive Economic Development Plans as Part of the 250-Acre Industrial Hemp Project in San Joaquin Sovereign Tribal Free Land MBS, California

Created on 2018-02-15 21:36:27

Cannabis Science and Free Spirit Organics Native American Corporation Report Positive Analytical Lab Results From Its 250-Acre, Industrial Hemp Research Project in San Joaquin Sovereign Tribal Free Land MBS, California

Created on 2018-02-15 21:35:30

Cannabis Science Announces Participation in Major U.S.-Africa Policy Forum in Washington, DC

Created on 2018-02-15 21:34:20

Cannabis Science Announces Publication of Initial Research Results Using Nanoparticle Drones to Target Lung Cancer With Radiosensitizers and Cannabinoids in the Renowned Journal Frontiers in Oncology

Created on 2018-02-15 21:27:44

  • Start
  • Prev
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • Next
  • End
REACH US.

2019 US Federal Contractor

DUNS number: 830406356
CAGE code: 5FZM9

NAICS Codes selected:

541711 - Research and Development in Biotechnology

621511 - Medical Laboratories

624230 - Emergency And Other Relief Services

Contact.

Cannabis Science Inc.

Mr. Raymond C. Dabney
President & CEO

raymond.dabney@cannabisscience.com



 
 
Copyright © 2019 Cannabis Science Inc. All Rights Reserved.